Biosimilarity Study of Subcutaneous Filgrastim in Healthy Volunteers

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

May 31, 2025

Conditions

Healthy

Interventions

BIOLOGICAL

Filgrastim Megalabs

Filgrastim Megalabs 5 μg/Kg/day, subcutaneous single dose

BIOLOGICAL

Granulokine

Granulokine 5 μg/Kg/day, subcutaneous single dose

All Listed Sponsors

lead

Megalabs

INDUSTRY

NCT04958772 - Biosimilarity Study of Subcutaneous Filgrastim in Healthy Volunteers | Biotech Hunter | Biotech Hunter